These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8213445)

  • 21. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of the diuretic and natriuretic effect of furosemide by the calcium antagonist nifedipine.
    Piryova B; Girchev R
    Acta Physiol Pharmacol Bulg; 1989; 15(1):13-8. PubMed ID: 2773646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M; Zimmermann J; Weil J; Gerzer R; Theisen K
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.
    Galluzzo A; Frea S; Boretto P; Pidello S; Volpe A; Canavosio FG; Golzio PG; Bergerone S; De Ferrari GM
    Clin Res Cardiol; 2020 Oct; 109(10):1251-1259. PubMed ID: 32144493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure.
    Aaser E; Gullestad L; Tølløfsrud S; Lundberg J; Hall C; Djøseland O; Kjekshus J; Forfang K
    Scand J Clin Lab Invest; 1997 Jul; 57(4):361-7. PubMed ID: 9249883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    Salah EM; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
    Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
    Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of captopril on urinary excretion of furosemide in hypertensive subjects.
    Fujimura A; Shimokawa Y; Ebihara A
    J Clin Pharmacol; 1990 Jun; 30(6):538-42. PubMed ID: 2191978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Captopril augments both basal and frusemide-induced natriuresis in normal man by suppression of circulating angiotensin II.
    Motwani JG; Struthers AD
    Br J Clin Pharmacol; 1992 Jul; 34(1):25-31. PubMed ID: 1633064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kidney excretory function and the effect of furosemide following the chronic use of captopril in rats].
    Pir'ova B; Nachev N; Gŭrchev R
    Eksp Med Morfol; 1985; 24(2):13-20. PubMed ID: 3905355
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of the diuretic, natriuretic, and kaluretic effects of furosemide when administered at 07:00 h and at 19:00 h.
    Hemal AK; Thind SK; Nath R; Sidhu HK; Sankaranarayanan A; Vaidyanathan S
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):314-6. PubMed ID: 3410608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal effects of captopril in chronic heart failure].
    Zolotov NA; Kiriaev AA; Merzon AK; Mukharliamov NM
    Ter Arkh; 1988; 60(8):46-51. PubMed ID: 3067412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N; Golik A; Dishi V; Zaidenstein R; Weissgarten J; Averbukh Z; Modai D
    Miner Electrolyte Metab; 1996; 22(4):248-52. PubMed ID: 8807629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diuretic effects of subcutaneous furosemide in human volunteers: a randomized pilot study.
    Verma AK; da Silva JH; Kuhl DR
    Ann Pharmacother; 2004 Apr; 38(4):544-9. PubMed ID: 14982985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omapatrilat: neurohormonal and pharmacodynamic profile when administered with furosemide.
    Uderman H; Vesterqvist O; Manning J; Ferreira I; Delaney C; Liao WC
    J Clin Pharmacol; 2001 Dec; 41(12):1291-300. PubMed ID: 11762556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.